Context Therapeutics (6K9.F) Q4 2024 Earnings

6NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.41
-0.29
-0.16
-0.04

Details

Expected EPS
-0.0825957
Actual EPS
-0.2019006
Surprise EPS
-0.12
Surprise Percent
+144.44%

Description

Context Therapeutics (6K9.F) has reported earnings of -0.2019006 per share for Q4 2024.

0 Comments

Share your thoughts